01 33BDSI
02 12INDIVIOR
03 52OREXO US INC
01 108147866
02 68470361
03 48475832
04 68658198
05 38703177
06 68940330
07 69259421
08 69439900
09 39522188
10 109655843
11 49687454
12 79901539
13 110874661
14 610946010
15 411020387
16 611020388
17 411135216
18 511433066
01 97Blank
01 85Y
02 12Blank
01 202027-07-23
02 62027-12-03
03 82029-08-07
04 42030-03-26
05 62030-05-22
06 32032-08-20
07 402032-09-18
08 72032-12-21
09 32035-04-24
Patent Expiration Date : 2032-12-21
US Patent Number : 9901539
Drug Substance Claim :
Drug Product Claim :
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2032-12-21
Patent Expiration Date : 2032-12-21
US Patent Number : 9901539
Drug Substance Claim :
Drug Product Claim :
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2032-12-21
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1769
Delist Requested :
Patent Use Description : TREATEMENT OF PAIN BY ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1769
Delist Requested :
Patent Use Description : TREATEMENT OF PAIN BY ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1769
Delist Requested :
Patent Use Description : TREATEMENT OF PAIN BY ...
Patent Expiration Date : 2027-07-23
